PSHP 2026 Residency Conference has ended

PSHP 2026 Residency Conference

10:40am EDT

Oral Stepdown Therapy for Gram-Negative Bacteremia in Obesity: High-Bioavailability Agents (Fluoroquinolones, Sulfamethoxazole-Trimethoprim) Versus Low-Bioavailability Agents (Beta-Lactams) a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Abigail Zim, PharmD

11:00am EDT

Oral Third Generation Cephalosporins versus Standard of Care for the Treatment of Penicillin-non-susceptible, Ceftriaxone-susceptible Alpha-hemolytic Streptococcal Infections a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Joseph Lalla

11:20am EDT

Comparison of Polymerase Chain Reaction (PCR) vs. Culture-Based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screenings on Time to Vancomycin De-escalation during Pneumonia Treatment a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Anna Nahirnyak

2:00pm EDT

Real-World Safety and Tolerability of Contemporary Dual Beta-Lactam Regimens Initiated During Hospitalization Broad Hub EASTSeung Ha • Bonny Brownstein • Joy Cao

2:20pm EDT

Real-World Implementation of Long-Acting Injectable Antiretroviral Therapy for HIV Treatment and Pre-Exposure Prophylaxis: Adherence, Retention, And Outcomes Broad Hub EASTSeung Ha • Bonny Brownstein • Audrey Siana PharmD.

2:40pm EDT

Evaluation of Antimicrobial Therapy and Clinical Outcomes for Patients with Streptococcus pneumoniae Bacteremia or Pneumonia with and without β-lactam Allergies Broad Hub EASTSeung Ha • Bonny Brownstein • Kaylee Goodson

9:00am EDT

Evaluating Early Transition from Intravenous to Oral Antibiotics for Adult Patients with Community Acquired Pneumonia a.Pavilion Hub WESTAdrienne Terico • Sara Groome • Adrienne Kroznuskie • Cole Anderson

9:20am EDT

Impact of Preoperative Antibiotic Timing on Odds of Surgical Site Infection a.Pavilion Hub WESTAdrienne Terico • Sara Groome • Adrienne Kroznuskie • Jovina Fager

9:40am EDT

Effect of Inhaled Amikacin Liposome Dose Adjustments on Treatment Outcomes in Pulmonary Non-Tuberculous Mycobacteria Infections a.Pavilion Hub WESTAdrienne Terico • Sara Groome • Adrienne Kroznuskie • Shaleen Ghosh

10:00am EDT

Treatment Outcomes in Patients with Fungal Infections After Implementation of Weight Based Micafungin Dosing at a Large Academic Medical Center a.Pavilion Hub WESTAdrienne Terico • Sara Groome • Adrienne Kroznuskie • Jane McNoble

10:30am EDT

Implementation of a Pharmacist-Driven Protocol for Ceftriaxone IV to PO Step-down in Hospitalized Patients with an Uncomplicated or Complicated Urinary Tract Infection a.Pavilion Hub EASTAlex Matika • Rebecca Buckler • Hinal Patel • Rachel Molino

10:50am EDT

Incidence of Piperacillin/Tazobactam Reactions in Patients with Reported Beta-Lactam Reactions in a Community Hospital Setting a.Pavilion Hub EASTAlex Matika • Rebecca Buckler • Hinal Patel • Brigid Hurst

11:10am EDT

Evaluation of Carbapenem Therapy for Extended Spectrum β-Lactamase producing Enterobacterales (ESBL-E) Bloodstream Infections in Patients with and without Hypoalbuminemia a.Pavilion Hub EASTAlex Matika • Rebecca Buckler • Hinal Patel • Thomas Hyson

11:30am EDT

Impact of a Pharmacist-Driven Antimicrobial Stewardship Initiative on Time to Targeted Therapy for Enterobacterales Bacteremia a.Pavilion Hub EASTAlex Matika • Rebecca Buckler • Hinal Patel • Emily Pinto